Prevalence of antibodies to Hepatitis C virus among Nigerian patients with HIV infection

Online Journal of Health and Allied Sciences

Volumn 4, Issue 2, 2005, Pages

  Inyama, Petrus Uchenna ^a   Uneke, Chigozie Jesse ^b   Anyanwu, Greg Ike ^a   Njoku, Okonkwo Moses ^c   Idoko, Julia Hauwa ^a   Idoko, John Alechenu ^a  

^a UNIVERSITY OF JOS   (Nigeria)

^b EBONYI STATE UNIVERSITY   (Nigeria)

^c GEDE AIDS/Infectious Diseases Research Institute   (Nigeria)

Author keywords

Hepatitis C virus; HIV; Nigeria

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NIGERIA; RISK REDUCTION; SAMPLE SIZE; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24144442889     PISSN: 09725997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Choo QL, Kuo G, Weiner AJ et al. Isolation of CDNA alone derived from a blood borne non A- non B hepatitis. Science 1989;224:359-62.
2. Albert A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999;31:17-24.
3. Seef LB. Natural history of hepatitis C. Am J Med 1999;107:10-15.
4. Highleyman L. HIV and hepatitis C coinfection. BETA 2003;15:32-44.
5. Piliero PJ, Faragon JJ. Case report. Hepatitis B virus and HIV coinfection. AIDS Read 2002;12:443-4, 448-51
6. Mutimer DJ, Olomu A, Skidmore S et al. Viral hepatitis in Nigeria -sickle cell disease and commercial blood donors. Q J Med 1994;87:407-11.
7. Federal Ministry of Health Nigeria. National HIV/AIDS and Reproductive Health Survey. Federal Ministry of Health Abuja, Nigeria. 2004:1-4.
8. Halim NK, Ajayi OI. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J. 2000;77:410-12.
9. Lesi OA, Kehinde MO. Hepatitis C virus infection in patients with sickle cell aanemia at the Lagos University Hospital. Niger Postgrad Med J 2003;10:79-83.
10. Halim NKD, Offor E, Ajayi OI. Epidemiologic study of the seroprevalence of hepatitis-B surface antigen (HBsAg) and HIV-1 in blood donors. Nig J Clin Pract 1992;2:42-5.
11. Baba MM, Gashau W, Hassan AW. Detection of hepatitis-B surface antigenaemia in patients mirth and without the manifestations of AIDS in Maiduguri, Nigeria. Nig Postgrad Med J 1998;5:125-8.
12. United Nations System in Nigeria. Nigeria Common Country Assessment: HIV/ AIDS. World Health Organization, Geneva. 2001:141-216.
13. Ockenga J, Stoll M, Tillmann HL, Trautwein C, Manns MP, Schmidt RE. Coinfection of hepatitis B and C in HIV infected patients. Wien Med Wochenschr 1997;471:439-42.
14. Amin J, Kaye M, Skidmore S, Pillay D, Cooper D, Dore G. HIV and hepatitis C coinfection within the CAESAR study. HIV Med 2004; 5:174-9.
15. Segurado AC, Braga P, Etzel A, Cardoso MR. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 2004;18:135-43.
16. Dimitrakopoulos A, Takou A, Haida A, Molangeli S, Gialeraki A, Kordossis T. The prevalence of hepatitis B and C in HIV-positive Greek patients; relationship to survival of deceased AIDS patients. J Infect 2000;40:127-31.
17. Lincoln D, Petoumenos K, Dore G J. HIV/HBV and HIV/HCV coinfection and outcomes following highly active antiretroviral therapy. HIV Med 2003;4:241-9.
18. Veruccli G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004;32:33-46.
19. Koziel MJ. New Insights in HIV and hepatitis C virus coinfection. Top HIV Med 2002;10:16-21.
20. Dienstag JL. Isselbacher KJ. Acute viral hepatitis. In: Fauci AS, Braunwald E, Isselbacher KJ, eds. Harrison's Principles of Internal Medicine, 14th edn. New York, Mc Graw-Hill, 1998;72-92.
21. Osmond DH. HIV Disease progression from infection to CDC-defined AIDS. In Cohen PT, Sande MA, Volberding PA eds. The AIDS Knowledge Base. New York, Little, Brown and company. 1994:1.7:1-1.7:19.
22. Drosten C, Nippraschk T, Manegold C, Meised H, Brixner V, Roth WK, Apedjinou A, Gunther S. Prevalence of hepatitis B virus DNA in anti-HBc- positive / HBsAg negative sera correlates with HCV but not HIV serostatus. J Clin Virol 2004;29:59-68.